Skip to content
 

Small Cap Stocks: ValiRx, Metals One, Keywords Studios, Bivictrix

*

There has been some significant interest in the AIM index this morning with more acquisition news arguably spurring interest in some of the undervalued small caps. The All Share is up more than 2% running into the close, adding more than 16 points to sit at 810.74 just after 4pm. That puts it on track for the biggest daily percentage gain in more than two years.

  • ValiRx +69%
  • Keywords Studios +58%
  • CT Automotive +21%
  • Metals One -19%
  • Bivictrix Therapeutics -13%

ValiRx LON:VAL was topping the board shortly before the bell, up some 69%. The stock started with losses in early trade but a lunchtime business update covering a range of projects was well received. Share have ultimately doubled from their opening levels although this needs to be taken in the context of longer term downtrend.

Keywords Studios LON:KWS also barrelled higher off the back of it confirming that a private equity suitor was actively pursuing the company. Having rejected four approaches already, the fifth bid of 2550p per share has been made public. Gains today saw the stock trade as high as 2400p before easing back slightly towards the close but still sitting around 58% higher.

Metals One [LON:MET1] was the day’s worst performer just before the bell, trading some 19% lower. That move came off the back of placing news although the weighty commitment by directors here is worthy of note.

Bivictrix Therapeutics LON:BVX was in second to last place, off 13%. However this is a thinly traded stock, there’s no news out and the move was within the quoted spread.

CT Automotive LON:CTA gets the notable mention, up 21% on the day. Final results this morning noted a strong rebound in 2023 as markets reopened post-COVID and whilst revenues were up, the more compelling argument was the increase in profit margins from 12% to 22%. Margin improvements are expected to deliver further benefits this year, too.

Looking for great investing ideas? Sign up to our free newsletter.

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

Aquis
CME Group
FP Markets
Pepperstone
TMX
WisdomTree
Back To Top